Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?
Giancarlo Marenzi
Correspondence Centro Cardiologico, Monzino, Via Parea 4, 20138 Milan, Italy
Email Giancarlo.marenzi@ccfm.it
This article has no abstract so we have provided the first paragraph of the full text.
The clinical and prognostic implications of CIN in patients undergoing PCI have been well documented.1 CIN prevention, however, remains a critical issue because effective therapy for this renal complication is still lacking. Although several risk factors have been recognized and many patients at increased risk are identified, risk profiles can differ substantially between patients according to the number of risk factors and their relevance.2
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
